Parallel Sessions / Sessions Parallèles
Thursday, 26 October
Innovative Solutions to Increase Young People’s Access to Contraceptives
Around the globe, access to reproductive healthcare can be a challenge, especially for young people. With the complexities of navigating their developmental transition into adulthood, young people require more thoughtful, strategic and innovative approaches to getting healthcare. From a centralized health hotline call center and health facility-based services in Malawi to a web-based application in Argentina,presenters will guide participants in this interactive session on how to use resources within and beyond the formal health system to help young people get access to the reproductive health supplies and services they want and need.
- Talimba Chisala Bandawe,National Program Coordinator for Unite for Body Rights & Women Deliver Young Leader, Malawi Sexual Reproductive Health Rights Alliance
- Alinafe Kasiya,PhD,Deputy Country Director,VillageReach
- Mariana Romero, Senior Researcher, CEDES
Challenges and Opportunities for Strengthening Contraceptive Security in Burkina Faso and Madagascar
Les défis et les opportunités rencontrées seront mis sur la table pour être discuter avecles autres parties prenantes dans le secteur afin de trouver un consensus pour assurer la pérennisation des actions entreprises.
Session présentée par:
- RasmanéBELEM,Chargé de la logistique de l'Association Burkinabé pour le Bien-Etre Familial (ABBEF) du Burkina Faso
- Lalaina RAZAFINIRINASOA, Directeur Pays du Marie Stopes International à Madagascar
durant laquelle les contextes de deux pays vont être exposés ainsi qu’un bref descriptif des deux associations, leurs visions, leurs missions et les valeurs respectives etpuis finalement leurs contributions à l’atteinte de objectifs nationaux dans la fourniture de service de santé de la reproduction et de la planification familiale.
A Systems Approach to Improving Method Choice in West African Private Health Facilities
Population-based data in West Africa indicate very lowuse of private for-profit facilities as a source of family planning services, particularly long-acting and reversible contraception (LARC). Drawing from recent private sector assessments in Benin, Côte d’Ivoire, Mali, and Senegal, this session discusses the use of a systems approach to address the unique constraints faced by private facilities, and sustainably improve their ability to offer quality FP services.
- Françoise Armand, Abt Associates
Approche Yeksi Naa au Sénégal: une initiative presqu’a cent pourcent
Yeksi Naa, une initiative presqu’a cent pourcent: plus de 98% de disponibilite des contraceptifs et autres produits de sante integres au bout du dernier kilometre, 100% de remontee des donnees du niveau service pour la gestion de la chaine d’approvisionnement et des programmes de sante publique, 100% de taux de recouvrement des couts pour assurer la perennite du systeme de distribution. Cette session vous en devoilera les secrets degrand-mere!
- Docteur Oumy Kalsoum NDIAYE NDAO, Spécialiste en Gestion Logistique
Increasing Access to Safe Abortion Commodities in Countries with Limited Legal Indications for Induced Abortions
Although the number of countries with mifepristone and misoprostol available grows every year, many women in francophone Africa and Latin America still do not have access to these important abortion medications. This panel will explore the barriers and opportunities for registration, marketing and subsequent availability of mifepristone and misoprostol these regions.
- Agustina Ramón Michel, Law professor, researcher adjunct at the health area of Centro de Estudios de Estado y Sociedad –CEDES, and member of CLACAI, “The Impact of policy and social attitudeson efforts to increase access to abortion medicines in Latin America”
- Manuelle Hurwitz, IPPF, London, “From registration to availability: Lessons from IPPF’s experience bring medical abortion pills to Francophone Africa”
- Jennifer Blum, Gynuity Health Projects “Development of additional maternal health uses of mifepristone and misoprostol as a strategy to facilitate registration of these medicines globally”
Effective Advocacy for RH Supplies: Experience from Madagascar and Tanzania
This session discusses effective advocacy initiatives conducted in Madagascar and Tanzania to address legal barriers limiting access to contraceptives. Abstracts for the session have the following titles:
- Plaidoyer efficace pour le vote d'une loi SRPF en moins d'un an a Madagascar(Effective advocacy for the vote of a SRPF law in less than a year in Madagascar) by Dr. Ralidera Onisoa Rindra, Management Sciences for Health(MSH).
- Overcoming Regulatory Barriers to Contraceptives Availability: A Case of Tanzania’s Public Procurement Act, 2016 by James Mlali of Advance Family Planning (AFP).
During this session, participants will learn about and discuss how advocacy interventions targeting law-making processes contribute to improving access to contraceptives. Presenters will share on their experiences, tactics they used, and challenges they encountered in the advocacy process.
- Onisoa Rindra Ralidera, Health Policy Plus Madagascar
- James Mlali, Advance Family Planning (AFP) in Tanzania
Moving from Problems to Progress: Using Market Shaping, Collaboration, and Visibility and Analytics to Increase Contraceptive Availability and Choice
This panel presentation will highlight the key global-level problem statements and advances that have helped move the family planning (FP) community towards improved contraceptive availability and choice as well as the future vision for an end-to-end global visibility analytics network (GVAN) to ensure more timely and cost-effective delivery of commodities to countries. It will summarize the market shaping investments made to reduce unmet need for implants, as well as the people, processes, and tools contributing to the success of the Coordinated Supply Planning (CSP)group, its critical role in data-sharing and data use for better decision-making, including to accelerate introduction of new and underused FP products, and the future vision for enhanced data visibility and use via the GVAN.
- Maryjane Lacoste,Senior Program Officer, Bill and Melinda Gates Foundation
- Maggie Murphy, Technical Advisor, JSI
- Julia White, Market Development Technical Officer,RHSC
Innovations in Access to Improved Menstrual Hygiene Commodities
Panelists will explore multiple avenues to increase access to quality menstrual products including government subsidies; use of information and communication technology to optimize product access; and private pharmacies and family planning services as mechanisms for menstrual cup distribution and payment. We will discuss the importance of selection criteria and standards as programs consider including menstrual products.
- Dr. Sushma Dureja, Deputy Commissioner, Adolescent Health Division, Ministry of Health and Family Welfare, Government of India.
- Joanna Bichsel, CEO and Co-Founder, Kasha. chains and health, agricultural, and financial services. Joanna grew up in Canada and lives in Rwanda with her husband and two young children.
- Shamirah Nakalema, Project Officer and Lead Trainer, WoMena Uganda.
- Nancy Muller, Senior Program Officer, PATH.
Approach for Engaging and Reaching Young People with the RH Supplies they Need
This session will explore promising practices that help ensure young people are involved and reached with responsive RH programmes and products. Two ignite presentations and a case study will provide a background to the discussions. The first presentation highlights a multi-sectoral approach applied to reach young people with FP and RH services in Diourbel, Senegal.The second presentation will focus on how young people in East Africa (Kenya, Uganda and Tanzania)have been trained and given opportunities to participate in policy and budget making processes thus ensuring their voices and needs on RH/FP are factored in government plans and expenditures. One of the youth champions from Kenya will share his experiences and the result of their active involvement in the processes and the impact it has had on young peoples’ access to RH commodities, information and services.
- Lucia LABOSO CHEBETT, Advocacy Manager, East Africaat Deutsche Stiftung Weltbevölkerung (DSW)
- Omar Mwamuye Bandika, Family Planning (FP) Youth Champion from Kilifi County in Kenya
- Diouf Ousmane, co-founder and coordinator of the National Youth Alliance for Reproductive Health and Family Planning of Senegal
New Product Introduction in West Africa
This session introduces two new methods of woman-initiated contraception and describes current efforts to introduce the products in West Africa. Participants will discuss lessons learned to-date and key considerations for broader introduction.
- Temple Cooley, PSI
- Babacar Mane, Population Council
- Wilberto Robles, WCGMahamane
- Badamassi Bacharou, PSI/Niger
La Surveillance Hebdo de 17 Produits de SR dans l’ensemble de la Chaine d’Appro au Burkina
La surveillance hebdomadaire des stocks de produits de Santé de la Reproduction au Burkina Faso une stratégie novatrice instaurée depuis 2012 par les autorités sanitaires pour le suivi des stocks des produits de santé de la reproduction avec l'utilisation de l'outil informatique (téléphone portable, PC et connexion internet) dans le but de prendre des décisions en fonction des faits logistiques pour maintenir une pleine disponibilité à tous les niveaux de la chaîne d'approvisionnement.
- Dr Souleymane YERE
Measuring the Empty Shelf: Progress and Trends Using the Universal Stockout Indicator
Stock-outs have an impact on contraceptive prevalence and method choice, and reducing contraceptive stock-outs is a critical measure of FP2020’ success. FP2020 stock-out indicators were adopted in 2015 after a consultative process led by the RHSC that resulted in the harmonization of various methods of measuring stock-outs. The FP2020 indicators include the Universal Stockout Indicator, which reflects the availability of specific family planning commodities at the facility level at a point of time (the day of the survey) (Core Indicator 10), and a second indicator that reflects stock-outs for a range of methods (Core Indicators 11a and 11b).
In this presentation,FP2020 will present on progress in aligning partners on stock out measurement and trends in reporting since adopting these indicators. Data on point in time stock-outs at the facility level are improving, and in 2016 were reported for 30 countries up from 13 in 2015. The number of countries able to report on stock-outs each year is expected to continue to improve through facility surveys conducted by UNFPA and PMA2020. Increased reporting will now allow for comparison in country stock out indicators over time to look at trends within and across countries. This presentation will use data from the last three years of FP2020 reporting (2015, 2016, and 2017) to explore trends in stockouts using the Universal Stockout Indicator and share lessons learned in reporting and presenting these data to different audiences. FP2020 stockout data for francophone Africa will receive a special focus and are now available for multiple years for several countries in the region.
- Ellen T. Tompsett, Global Collaboration Manager for Population and Reproductive Health, USAID Global Health Supply Chain-Procurement and Supply Management (GHSC-PSM)
- Michelle Weinberger, Senior Associate, Avenir Health
- Martyn Smith, Managing Director, FP2020
Friday, 27 October
Safe Abortion Commodities on Both Sides of the Counter: Experiences from Cameroon and Nigeria
Ipas will present results from their Innovation Fund Award to pilot test supply management mobile phone applications that allow users to calculate their supply needsfor manual vacuum aspirators (MVA) and medical abortion (MA) commodities (misoprostol and misoprostol/mifepristone combination packs). The goal of the pilot project was to ensure accuracy, usability, and feasibility of the mobile commodity calculation tools; results showed that most participants found the mobile tools easy to use for calculating and ordering supplies and that the mobile tools had a positive impact on their job performance.
The availability of misoprostol is a key factor in improving maternal health in Cameroon. Despite the drug presence on the Essential Medecine List, information on access and use is still limited.
- Briton Bieze, MPH, Supply Chain Manager, Ipas
- Nènè Fofana-Cissé, Population Services International
The Female Condom: Lessons Learned and Opportunities for Expansion
This presentation focuses on providing solutions regarding market functions of the female condom that some key stakeholders claim do not function. The three panelists will show through their research and evidence, what the right way is to address market functions of female condoms in order to create sustainable and successful markets and programs.
- Chastain Mann, Chief Executive Officer, Mann Global health
- Denise van Dijk, President, Female Health Company
- Marina Tiroyan, Market Research Advisor, i+solutions
Game On: Building Capacity with a Fun, Engaging SCM Digital Game
John Snow, Inc.’s inSupply project developed the HealthGamesKenya (HGK) mobile Health Supply Chain Management game to help health workers acquire or update their supply chain management skills on their own schedules and to promote actualization of a virtual health supply chain community. Join us to play the game and compete with your fellow attendees to build your supply chain management knowledge. Please bring your mobile phone, tablet, or laptop to the session in order to play the game.
- Yasmin Chandani, Project Director, inSupply, John Snow, Inc.
Le Voyage vers l’Auto-Injection de DMPA-SC au Sénégal
Cette session dresse les enjeux de l’auto-injection du DMPA en sous-cutanée en Afrique subsaharienne. Des résultats de recherche montrant les défis, potentiels et perspectives de l’auto-injection vont être présentés, ainsi que l’exploration d’un marché propice à l’auto-injection.
- BA Maymouna, Coordinatrice de recherche-Sayana Press, PATH Sénégal
- Seynabou Kassé, Responsable Regional de Programme, MSI Sénégal
Manufacturer Incentives for Local Market Investment
This session will provide an opportunity for the audience to hear directly from manufacturers what drives their strategies for private sector investment. It will take place in a more informal roundtable discussion format focusing on the following discussion questions: 1) What kind of procurement incentives can procurers leverage in RFPs that will incentivize you to grow your private sector brand(s)? 2) What fundamental shifts (in policy or practice) need to happen at the country level to make LIC/LMIC markets attractive for investment? 3) How do you approach the total market and assessing total market opportunities? 4) From your experience LAC, Nigeria, South Africa what are the market factors that are most critical to a supportive environment for private sector investment? 5) What are the top 2 things the global community can do to encourage private sector investment growth by manufacturers? The panelists will then take questions and engage the audience in a discussion around the aforementioned questions.
- Anita Deshpande, Managing Consultant at IBM and serves as a market shaping subject matter expert for the USAID Global Health Supply Chain Procurement and Supply Management Program
- Gibran Abidin, Commissioner, PT Tunggal Idaman Abdi
- Klaus Brill, Vice President Corporate Commercial Relations, Bayer Pharma AG
RH Supply Chain Challenges in Humanitarian Settings: Global to Local Perspectives
Globally, an estimated 128.6 million people are currently in need of humanitarian assistance; approximately one-fourth are women and girls of reproductive age. Yet RH commodities are often unavailable during humanitarian response and recovery, forcing many women and girls to contend with an unmet need for contraceptives and unplanned pregnancies in addition to conflict, disaster, and displacement. This panel will discuss challenges in reproductive health supply chains in humanitarian settings from global to local levels, and opportunities for global and national advocates to improve access to RH supplies for people affected by crises.
- Sarah Rich Senior Program Officer for Sexual and Reproductive Health, Women’s Refugee Commission
TMA for Family Planning
UNFPA and the Bill & Melinda Gates Foundation conducted separate studies in 2016-17 analyzing total markets for contraceptives and condoms. The studies in 11 African countries pointed to priority market development measures to make these health product markets more sustainable and equitable, in the face of declining donor funding.
- UNFPA (Dr. Kanyanta Sunkutu)
- Bill and Melinda Gates Foundation (Maryjane Lacoste)
- Mann Global Health (Chastain Mann,moderator)
The Long Road to Product Availability: the Heat Stable Carbetocin Experience
Getting maternal health products to the women who need them is a long and complicated process. In this session,our experts will discuss a number of the important steps in the process of making a product available at the country level in the context of a product currently being prepared for the low-income country market including:
- Evidence and Guidelines -how clinical evidence is used to develop country guidelines
- Product development and registration –from the challenges of developing a high quality, low cost product and the process of transferring technology to the factors considered when selecting an appropriate regulatory pathway
- Advocacy Issues –the financial case and the role of the GFF
- Taiwo Oyelade, MD, Public Health Physician, MBBS, MPHWHO Country Office, Nigeria
- Dr. Aminu Magashi Garba, MD, MPHAfrica Health Budget Network and GFF Civil Society Representative
- Mr Lester Chinery, Concept Foundation
Next Generation CIPs: Evolutions in Commodities and Method Mix
Many countriesare developing their second round of costed implementation plans (CIP) for family planning. Since the first CIP, method mix may have shifted for a variety of reasons including a focus on youth and the overall growth in number of women using contraceptives. This session will examine the differences between the two CIP generations, examining the method mix, modern contraceptive prevalence rate projections, and overall costs of the CIPs.
- Modibo Maiga, Regional Director, West Africa, Palladium
- Sara Stratton, Senior Technical Advisor, Family Planning, Palladium
Informed Push Model: Lessons learned for Future Applications
This session will describe the different environmental factors that influenced the success/failure of Informed Push models (IPM) implemented in Nigeria, Tanzania, Senegal, and elsewhere. An in-depth look at Senegal will then examine the lessons learned from the IPM and costs, with a view to informing future applications in other countries.
- Thidiane Ndoye, Family Planning/Reproductive Health Task Order Director, GHSC-PSM
- Dr. Adama Faye, specialist in Public Health, Epidemiology and Biostatistics.
Sustainability of optimal availability of contraceptives until the last mile. Lessons learned in Burundi and the mountainous Kivu provinces of the DRC
In this panel Mr. Sosthène SINARINZI,Director of Administration and Finance of the National Program for Reproductive Health of Burundi will discuss sustainable improvements in the supply chain management of contraceptives in Burundi. The discussion will highlight the collaborative efforts of i+solutions, UNFPA and other partners under the leadership of the Government of Burundi, to ensure the availability of quality and affordable contraceptives in the last mile. Dr Socrate Cuma Byamungu, SRH expert of the National Program for Reproductive Health of South Kivu, Democratic Republic of Congo will present innovative sustainable pathways to resolve last mile challenges in the Kivu provinces.
- Michel Yalaza, i+solutions
- Sosthène SINARINZ, Director of Administration and Finance of the National Program for Reproductive Health in Burundi (PNSR / BURUNDI)
- Frank Roijmans, Senior Advisor Reproductive Health Programs, i+ solutions
- Landry Medegan, i+solutions
- Yolande Magonyagi, Doctor specialized in reproductive health including family planning
- Socrate Cuma BYAMUNGU, meber of National Program for Reproductive Health (PNSR) in South Kivu DRC
Accelerating Impact: Identifying Strategies to Increase Availability & Affordability of the LNG-IUS
One of the most effective methods of reversible contraception available, the levonorgestrel intrauterine system (LNG-IUS), remains out of reach for most women in developing countries primarily due to cost barriers. This session will explore the progress the global community has made recently to evaluate potential demand for the method, and to identify opportunities to further increase accessibility and affordability.
- Sarah Shaw, MSI
- Kate Rademacher, FHI 360
- Temple Cooley, PSI